Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
07/10/2008 | WO2008011621A3 Protein kinase c zeta inhibition to treat vascular permeability |
07/10/2008 | WO2008005084A3 Methods to prevent and treat diseases |
07/10/2008 | WO2007149406A3 Modified coagulation factor ix polypeptides and use thereof for treatment |
07/10/2008 | WO2007133865A3 Hcv/hiv inhibitors an their uses |
07/10/2008 | WO2007121318A3 Formulations for delivering insulin |
07/10/2008 | WO2007121256A3 Rapid acting and long acting insulin combination formulations |
07/10/2008 | WO2007073486A3 Methods and compositions for delivering active agents with enhanced pharmacological properties |
07/10/2008 | WO2004083365A9 Compounds and their use for specific and simultaneous inhibition of genes involved in diseases and related drugs |
07/10/2008 | WO2002102229A9 Diagnosing tumorigenicity and determining resistance to anticancer therapy |
07/10/2008 | WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling |
07/10/2008 | US20080168584 Using vector transformation to insert plasmid which express antisense sequences which reduce proanthocyanidin (PA) in plant seed coats; enhancing feed quality and digestibility |
07/10/2008 | US20080167457 Nonhuman model animal lacking the ability to control lymphocyte migration |
07/10/2008 | US20080167451 Method for isolating an intestinal cholesterol binding protein |
07/10/2008 | US20080167448 Immunoglobulin specific to prostate tumor associated protein (24P4C12) for use in diagnosis, prevention and treatment of cell proliferative disorders |
07/10/2008 | US20080167388 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
07/10/2008 | US20080167365 Of the ACE inhibitor ramipril by mixing with the ramipril (m)ethyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
07/10/2008 | US20080167280 Enhanced drug delivery in transdermal systems |
07/10/2008 | US20080167257 Therapy of acroparaesthsia, allergic (psoric) conditions, allergic reactions, alopecia, amnesia, anaphrodisia, angina, arthritis, asthenopia, biliary sycosis, burns, cancerous conditions, such as colon cancer, malignant melanoma and malignant nasal polyps, carpal tunnel syndrome, colds, conjunctivitis |
07/10/2008 | US20080167253 Antiinflammatory agents; antiarthritic agents; antiscarring agents; isolated oligopeptide which can be obtained from the microorganism Entamoeba histolytica or synthesized |
07/10/2008 | US20080167252 Method for Treating a Patient Undergoing Chemotherapy |
07/10/2008 | US20080167251 Angiotensin-(1-7) and Angiotensin-(1-7) Agonists for Inhibition of Cancer Cell Growth |
07/10/2008 | US20080167250 Method For Induction and Enhancement of Apoptosis In Tumor Cells |
07/10/2008 | US20080167249 Protective factors against inflammation, burns and noxious stimuli |
07/10/2008 | US20080167248 Anti-Aging Effects Of Substance P |
07/10/2008 | US20080167247 modulator of PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof; treatment of pain, cancer |
07/10/2008 | US20080167246 Ophthalmic and Contact Lens Solutions Containing Peptides as Preservative |
07/10/2008 | US20080167245 Novel metastasis suppressor gene on human chromosome 8 |
07/10/2008 | US20080167244 Use of il-28 and il-29 to treat cancer and autoimmune disorders |
07/10/2008 | US20080167243 immunizing a subject with a sufficient amount of a translated polypeptide to produce antibody; containing a phenylalanine or tyrosine derivative analoges |
07/10/2008 | US20080167242 Toll-like receptor agonists and antagonists and methods of use thereof |
07/10/2008 | US20080167241 Mu-1, member of the cytokine receptor family |
07/10/2008 | US20080167240 Albumin Fusion Proteins |
07/10/2008 | US20080167239 Albumin Fusion Proteins |
07/10/2008 | US20080167238 Albumin Fusion Proteins |
07/10/2008 | US20080167237 Methods and compositions for healing and repair of articular cartilage |
07/10/2008 | US20080167236 Methods and compositions for healing and repair of articular cartilage |
07/10/2008 | US20080167235 Methods and compositions for healing and repair of articular cartilage |
07/10/2008 | US20080167234 Polypeptide does not contain a vertebrate high mobility group box protein (hmgb), that inhibit the release of a proinflammatory cytokine; treating inflammatory disease, autoimmune disease with monoclonal antibody or antigen-binding fragment |
07/10/2008 | US20080167233 treating papilloma by administering biologically a complex of alpha-lactalbumin in the apo folded state and a cis C18 unsaturated fatty acid cofactor which stabilizes the complex in a biologically active form |
07/10/2008 | US20080167232 Anti-angiogenic and anti-tumor properties of vascostatin and other indogen domains |
07/10/2008 | US20080167231 Modified Corticotropin Releasing Factor Peptides and Uses Thereof |
07/10/2008 | US20080167230 treating asthma by administering a trefoil peptide, the human intestinal trefoil factor (ITF), cyclic peptides |
07/10/2008 | US20080167229 Inhibitors of USP1 deubiquitinating enzyme complex |
07/10/2008 | US20080167228 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
07/10/2008 | US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies |
07/10/2008 | US20080167226 solution contains GLP-1(7-37) or an analogue wherein an amino acid residue of the parent peptide has a lipophilic substituent attached optionally via a spacer; pH is 7-10; stability, long shelf life; biodrug for stimulating insulin secretion, lowing blood glucose |
07/10/2008 | US20080167225 Providing an osteogenic protein in a biocompatible bioresorbable carrier to defect locus, thereby inducing formation of functional replacement cartilage tissue, repairing a defect in an intervertebral disc |
07/10/2008 | US20080167224 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases |
07/10/2008 | US20080167223 Methods and Compositions for Using Tsh in the Inhibition of Tnf Activity |
07/10/2008 | US20080167222 Use of Growth Hormone Releasing Factor Analogs in Treating Patients Suffering From Wasting |
07/10/2008 | US20080167221 Heterocarpine, a plant-derived protein with anti-cancer properties |
07/10/2008 | US20080167220 Methods for selectively inhibiting janus tyrosine kinase 3 (jak3) |
07/10/2008 | US20080167219 converting factor IX into a molecule with enhanced activity which provides an alternative for replacement therapy and gene therapy for hemophilia B. Using recombinant techniques, factor IX with replacement at positions 86, 277, and 338 exhibits better clotting activity than recombinant wild type factor |
07/10/2008 | US20080167218 stability and uniformity of a PEGylated G-CSF polypeptide having at least one PEG moiety attached to the epsilon amino group of a lysine residue or the N-terminal amino group and at least one PEG moiety attached to a hydroxyl group |
07/10/2008 | US20080167216 for treating Parkinson's disease in a mammal, comprising:providing a quantity of a viral vector expressing an N-terminal of sonic hedgehog ("ShhN"); andadministering a therapeutically effective amount of the quantity of viral vector to the mammal. |
07/10/2008 | US20080167199 Multimerization of HIV-1 vif protein as a therapeutic target |
07/10/2008 | US20080166800 Method and medicament for inhibiting the expression of a given gene |
07/10/2008 | US20080166783 In vivo incorporation of unnatural amino acids |
07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
07/10/2008 | US20080166765 Fungal cell wall synthesis gene |
07/10/2008 | US20080166763 Human toll homologues |
07/10/2008 | US20080166755 Intracellular delivery of osteoinductive proteins and peptides |
07/10/2008 | US20080166730 Therapeutic and diagnostic proteins comprising a SOCS box |
07/10/2008 | US20080166724 VEGF-Modulated Genes and Methods Employing Them |
07/10/2008 | US20080166698 Antibodies for cancer therapy and diagnosis |
07/10/2008 | US20080166428 Utilizing glutathione S transferase (GST) activated glutamyl-3-[[2-[[bis[bis(2-choroethyl)-amino]phosphinyl]oxy]ethyl]sulfonyl]-L-alanyl-2-phenyl-glycine (canfosfamide) |
07/10/2008 | US20080166414 Delivery particles having surface altering agent; transfection efficiency |
07/10/2008 | US20080166401 For treatment of inflammatory, ischemic or degenerative disorders |
07/10/2008 | US20080166399 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
07/10/2008 | US20080166394 For reducing cancer risks |
07/10/2008 | US20080166392 Synthetic peptides having non-growth factor heparin binding region, linker, and sequences that bind specifically to receptor; degenerative joint disease |
07/10/2008 | US20080166391 Zero-order prolonged release coaxial implants |
07/10/2008 | US20080166387 Anti-angiogenic compositions and methods of use |
07/10/2008 | US20080166376 Nucleic acids, proteins and vectors containing a nucleotide sequence encoding a full-length or a truncated form of the 60kCRMP gene product of a strain of Chlamydia; vaccines |
07/10/2008 | US20080166373 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-alpha NUCLEIC ACIDS |
07/10/2008 | US20080166360 Recombinant pollen protein for use in diagnosis, prevention and treatment of allergies |
07/10/2008 | US20080166356 Treating bone disorders resulting in increased trabecular bone formation, decreased osteoblast and osteocyte apoptosis and increased osteoprogenitor differentiation |
07/10/2008 | US20080166354 Using monoclonal antibody specific to inhibitor of protease or of a non-proteolytic matrix-degrading enzyme (IPNME) as therapeutic tool in treatment of cell proliferative disorders |
07/10/2008 | US20080166352 B7 related protein-1specific immunogobulin for use in treatment and prevention of asthma, skin, rheumatic and autoimmune disorders |
07/10/2008 | US20080166349 Method to Inhibit the Propagation of an Undesired Cell Population |
07/10/2008 | US20080166340 Monoclonal antibodies for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapeutics and cancer |
07/10/2008 | US20080166335 Slimming Cosmetic Composition Comprising a Metalloproteinase as an Active Agent |
07/10/2008 | US20080166334 Pharmaceutical preparation comprising digestive/pancreatic enzymes for use in treatment of pancreatic insufficiency |
07/10/2008 | US20080166333 Bi-stable quantum wire array of self-assembled nanomedicine and the preparation method therefor |
07/10/2008 | US20080166332 Methods of Treatment of Amyloidosis Using Subsituted Ethanolcyclicamine Aspartyl Protease Inhibitors |
07/10/2008 | US20080166319 Modified cytokine for use in treatment and prevention of viral infection, cell proliferative and autoimmune diseases |
07/10/2008 | US20080166318 Methods and therapeutic combinations for the treatment of demyelination |
07/10/2008 | US20080166294 Compositions and methods for the treatment of tumor of hematopoietic origin |
07/10/2008 | US20080166293 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
07/10/2008 | DE102007043859A1 Mineralisierte Polypeptidsubstanz für den Knochenaufbau und deren Herstellung Mineralized Polypeptidsubstanz for bone formation and their preparation |
07/10/2008 | CA2711003A1 Targeting of ews-fli1 as anti-tumor therapy |
07/10/2008 | CA2677202A1 Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from hiv-tat |
07/10/2008 | CA2674538A1 An insulinotropic complex using an immunoglobulin fragment |
07/10/2008 | CA2674313A1 Romidepsin-based treatments for cancer |
07/10/2008 | CA2674209A1 Glp-1 pharmaceutical compositions |
07/10/2008 | CA2674186A1 Use of somatostatin analogs in cluster headache |
07/10/2008 | CA2673996A1 Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof |
07/10/2008 | CA2673870A1 Compositions and methods for the treatment of infections and tumors |
07/10/2008 | CA2673752A1 Compositions and methods for stimulating an immune response |
07/10/2008 | CA2673659A1 Methods of detecting and diagnosing inflamatory responses and disorders by determining the level of soluble b7-h4 |